Rekah Pharmaceutical Industry Ltd (REKA) — Free Cash Flow Generation Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Free Cash Flow Generation Index of 0.60x as of December 2025. Free cash flow of ILA3.17 Million represents 1% of operating cash flow (ILA5.27 Million). Read Rekah Pharmaceutical Industry Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Rekah Pharmaceutical Industry Ltd across 21 annual periods. Explore Rekah Pharmaceutical Industry Ltd (REKA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Rekah Pharmaceutical Industry Ltd. For the full company profile including market capitalisation, see REKA market cap.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | ILA5.92 Million | ILA12.95 Million | ILA7.03 Million | ▼ -32.0% |
| 2024 | 0.67x | ILA17.84 Million | ILA26.54 Million | ILA8.70 Million | ▲ +13.0% |
| 2023 | 0.59x | ILA16.86 Million | ILA28.35 Million | ILA11.49 Million | ▼ -26.4% |
| 2022 | 0.81x | ILA31.52 Million | ILA39.00 Million | ILA7.48 Million | ▲ +138.4% |
| 2021 | 0.34x | ILA7.17 Million | ILA21.17 Million | ILA13.99 Million | ▲ +150.6% |
| 2020 | -0.67x | ILA-7.55 Million | ILA11.28 Million | ILA18.84 Million | ▼ -97.6% |
| 2019 | -0.34x | ILA-11.48 Million | ILA33.91 Million | ILA45.40 Million | ▼ -377.7% |
| 2018 | 0.12x | ILA2.11 Million | ILA17.28 Million | ILA15.18 Million | ▼ -60.3% |
| 2017 | 0.31x | ILA7.32 Million | ILA23.80 Million | ILA16.48 Million | ▼ -25.2% |
| 2016 | 0.41x | ILA9.38 Million | ILA22.82 Million | ILA13.44 Million | ▲ +132.5% |
| 2015 | -1.26x | ILA-7.34 Million | ILA5.81 Million | ILA13.15 Million | ▲ +90.6% |
| 2014 | -13.49x | ILA-17.94 Million | ILA1.33 Million | ILA19.27 Million | ▼ -2256.8% |
| 2013 | 0.63x | ILA7.32 Million | ILA11.71 Million | ILA4.38 Million | ▲ +103.3% |
| 2012 | 0.31x | ILA4.36 Million | ILA14.18 Million | ILA9.82 Million | ▼ -85.8% |
| 2010 | 2.17x | ILA14.61 Million | ILA6.73 Million | ILA7.87 Million | ▲ +59.7% |
| 2009 | 1.36x | ILA35.36 Million | ILA26.03 Million | ILA9.33 Million | ▼ -48.4% |
| 2008 | 2.63x | ILA17.30 Million | ILA6.57 Million | ILA10.73 Million | ▲ +84.9% |
| 2007 | 1.42x | ILA17.73 Million | ILA12.45 Million | ILA5.28 Million | ▼ -46.4% |
| 2005 | 2.66x | ILA11.36 Million | ILA4.27 Million | ILA7.09 Million | ▲ +110.5% |
| 2004 | 1.26x | ILA22.57 Million | ILA17.87 Million | ILA4.70 Million | ▲ +3.7% |
| 2002 | 1.22x | ILA13.64 Million | ILA11.21 Million | ILA2.44 Million | — |